These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26267332)

  • 1. A 2009 cross-sectional survey of procedures for post-mortem management of highly infectious disease patients in 48 isolation facilities in 16 countries: data from EuroNHID.
    Fusco FM; Scappaticci L; Schilling S; De Iaco G; Brouqui P; Maltezou HC; Brodt HR; Bannister B; Ippolito G; Puro V;
    Infection; 2016 Feb; 44(1):57-64. PubMed ID: 26267332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic issues and capabilities in 48 isolation facilities in 16 European countries: data from EuroNHID surveys.
    Thiberville SD; Schilling S; De Iaco G; Fusco FM; Thomson G; Maltezou HC; Gottschalk R; Brodt RH; Bannister B; Puro V; Ippolito G; Brouqui P;
    BMC Res Notes; 2012 Sep; 5():527. PubMed ID: 23009598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection control management of patients with suspected highly infectious diseases in emergency departments: data from a survey in 41 facilities in 14 European countries.
    Fusco FM; Schilling S; De Iaco G; Brodt HR; Brouqui P; Maltezou HC; Bannister B; Gottschalk R; Thomson G; Puro V; Ippolito G;
    BMC Infect Dis; 2012 Jan; 12():27. PubMed ID: 22284435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EuroNHID checklists for the assessment of high-level isolation units and referral centres for highly infectious diseases: results from the pilot phase of a European survey.
    Fusco FM; Schilling S; Puro V; Brodt HR; Follin P; Jarhall B; Bannister B; Maltezou HC; Thomson G; Brouqui P; Ippolito G;
    Clin Microbiol Infect; 2009 Aug; 15(8):711-9. PubMed ID: 19486074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection control practices in facilities for highly infectious diseases across Europe.
    Maltezou HC; Fusco FM; Schilling S; De Iaco G; Gottschalk R; Brodt HR; Bannister B; Brouqui P; Thomson G; Puro V; Ippolito G;
    J Hosp Infect; 2012 Jul; 81(3):184-91. PubMed ID: 22648013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation facilities for highly infectious diseases in Europe--a cross-sectional analysis in 16 countries.
    Schilling S; Fusco FM; De Iaco G; Bannister B; Maltezou HC; Carson G; Gottschalk R; Brodt HR; Brouqui P; Puro V; Ippolito G;
    PLoS One; 2014; 9(10):e100401. PubMed ID: 25350843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries.
    De Iaco G; Puro V; Fusco FM; Schilling S; Maltezou HC; Brouqui P; Gottschalk R; Bannister B; Brodt HR; Siikamaki H; Perronne C; Brantsæter AB; Fjellet AL; Ippolito G;
    Infect Control Hosp Epidemiol; 2012 Oct; 33(10):1008-16. PubMed ID: 22961020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosecurity measures in 48 isolation facilities managing highly infectious diseases.
    Puro V; Fusco FM; Schilling S; Thomson G; De Iaco G; Brouqui P; Maltezou HC; Bannister B; Gottschalk R; Brodt HR; Ippolito G;
    Biosecur Bioterror; 2012 Jun; 10(2):208-14. PubMed ID: 22571373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transportation capacity for patients with highly infectious diseases in Europe: a survey in 16 nations.
    Schilling S; Maltezou HC; Fusco FM; De Iaco G; Brodt HR; Bannister B; Brouqui P; Carson G; Puro V; Gottschalk R; Ippolito G;
    Clin Microbiol Infect; 2019 Apr; 21S():e1-e5. PubMed ID: 24750421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Level Isolation Unit Infection Control Procedures.
    Herstein JJ; Biddinger PD; Gibbs SG; Le AB; Jelden KC; Hewlett AL; Lowe JJ
    Health Secur; 2017; 15(5):519-526. PubMed ID: 29058966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats.
    Nisii C; Castilletti C; Di Caro A; Capobianchi MR; Brown D; Lloyd G; Gunther S; Lundkvist A; Pletschette M; Ippolito G;
    Clin Microbiol Infect; 2009 Aug; 15(8):720-6. PubMed ID: 19754729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries.
    Fusco FM; Puro V; Baka A; Bannister B; Brodt HR; Brouqui P; Follin P; Gjorup IE; Gottschalk R; Hemmer R; Hoepelman IM; Jarhall B; Kutsar K; Lanini S; Lyytikainen O; Maltezou HC; Mansinho K; Marti MC; Ott K; Peleman R; Perronne C; Sheehan G; Siikamakii H; Skinhoj P; Trilla A; Vetter N; Ippolito G
    J Hosp Infect; 2009 Sep; 73(1):15-23. PubMed ID: 19647337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosafety Requirements for Autopsies of Patients with COVID-19: Example of a BSL-3 Autopsy Facility Designed for Highly Pathogenic Agents.
    Loibner M; Langner C; Regitnig P; Gorkiewicz G; Zatloukal K
    Pathobiology; 2021; 88(1):37-45. PubMed ID: 33296902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
    Nisii C; Castilletti C; Raoul H; Hewson R; Brown D; Gopal R; Eickmann M; Gunther S; Mirazimi A; Koivula T; Feldmann H; Di Caro A; Capobianchi MR; Ippolito G
    PLoS Pathog; 2013 Jan; 9(1):e1003105. PubMed ID: 23349630
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S. Medical Examiner/Coroner capability to handle highly infectious decedents.
    Le AB; Brooks EG; McNulty LA; Gill JR; Herstein JJ; Rios J; Patlovich SJ; Jelden KC; Schmid KK; Lowe JJ; Gibbs SG
    Forensic Sci Med Pathol; 2019 Mar; 15(1):31-40. PubMed ID: 30402743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Containment Care Units for Managing Patients With Highly Hazardous Infectious Diseases: A Concept Whose Time Has Come.
    Kortepeter MG; Kwon EH; Hewlett AL; Smith PW; Cieslak TJ
    J Infect Dis; 2016 Oct; 214(suppl 3):S137-S141. PubMed ID: 27651413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosafety considerations for autopsy.
    Nolte KB; Taylor DG; Richmond JY
    Am J Forensic Med Pathol; 2002 Jun; 23(2):107-22. PubMed ID: 12040252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facing highly infectious diseases: new trends and current concepts.
    Brouqui P
    Clin Microbiol Infect; 2009 Aug; 15(8):700-5. PubMed ID: 19486075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.